Medical device cyber security is becoming a regulatory priority as the UK government advances the Cyber Security and Resilience Bill through Parliament. While much of the public discussion has focused on hospitals and critical national infrastructure, the proposed legislation carries significant implications for medical device manufacturers, digital health providers and the wider healthcare supply chain.
The direction of travel is clear. Cyber security is no longer viewed solely as an IT responsibility. It is increasingly framed as a matter of patient safety, operational continuity and national resilience.
Why the Cyber Security and Resilience Bill Matters to MedTech
The proposed legislation aims to strengthen cyber defences across essential services including healthcare, energy, transport and water. Crucially, it expands regulatory expectations beyond frontline organisations to include the suppliers and technology providers that underpin those services.
For the medical technology sector, this is a major shift.
Many medical devices now operate as connected systems, integrating with hospital networks, cloud platforms and diagnostic workflows. As a result, device manufacturers and software providers are no longer peripheral to cyber risk. They are part of the healthcare operational ecosystem itself.
Under the proposals, organisations providing digital services or holding trusted access into critical environments may be required to meet defined cyber security duties, including:
- Stronger security controls and resilience planning
- Mandatory incident reporting obligations
- Greater accountability for supply chain security
- Demonstrable preparedness for cyber incidents
This moves cyber security from best practice into expected practice.
Supply Chain Security Moves Centre Stage
One of the most important aspects of the Bill is the ability for regulators to designate critical suppliers to essential services.
This has direct relevance to medical device companies.
Organisations supplying diagnostics platforms, connected monitoring devices, imaging systems or healthcare software may fall within scope where disruption could affect patient care or service delivery.
Recent incidents across healthcare have demonstrated how vulnerabilities in suppliers can cascade into widespread operational disruption. The government’s approach recognises that resilience cannot stop at organisational boundaries.
Healthcare resilience now depends on the collective security posture of the entire supply chain.
For medical device manufacturers, this means cyber security maturity will increasingly influence procurement decisions, partnerships and long-term market access.
New Incident Reporting Expectations
The Bill introduces stricter reporting timelines designed to improve national response coordination.
Organisations in scope may be required to:
- Notify regulators and the National Cyber Security Centre within 24 hours of a significant incident
- Provide a fuller technical report within 72 hours
- Inform affected customers quickly where disruption is likely
For medical device providers, this creates practical challenges:
- Detecting incidents rapidly across distributed environments
- Understanding clinical or operational impact quickly
- Maintaining clear governance and response ownership
- Producing defensible incident assessments under time pressure
Many organisations discover during incident simulations that technical detection is not the limiting factor. Decision making, communication and evidence gathering are.
Preparation therefore becomes as important as prevention.
Medical Devices as Part of Critical Infrastructure
The government has increasingly framed cyber security as national security, reflecting the real-world consequences of disruption to healthcare services.
Connected medical technologies now support:
- Diagnostics and laboratory processing
- Patient monitoring and remote care
- Clinical decision systems
- Operational hospital workflows
When these systems fail, the impact is not abstract. Appointments are cancelled, treatments delayed and patient safety potentially affected.
The Bill acknowledges this reality by strengthening oversight across the digital ecosystem supporting essential services, rather than focusing solely on core operators such as NHS trusts.
This represents a broader recognition that modern healthcare infrastructure is digital infrastructure.
Governance and Board Level Accountability
Another important shift introduced by the proposed legislation is governance visibility.
Cyber resilience is increasingly becoming a board level responsibility. Organisations must be able to demonstrate not only technical controls but also leadership oversight, risk understanding and response readiness.
For medical device organisations, this may require closer collaboration between:
- Engineering teams
- Security functions
- Regulatory compliance leads
- Executive leadership
Cyber security is moving closer to existing medical device safety principles. Just as quality management systems ensure product safety, cyber resilience is becoming part of operational assurance.
Preparing for the Direction of Travel
Although the Cyber Security and Resilience Bill remains in the Parliamentary process, its intent is already influencing regulators, procurement frameworks and industry expectations.
Medical device organisations should begin preparing now by focusing on several key areas:
1. Visibility
Understand where devices connect, what data flows exist and which environments depend on your systems.
2. Detection and Response
Ensure incidents can be identified quickly and investigated with clear ownership.
3. Supply Chain Assurance
Assess dependencies on third parties and managed services.
4. Governance Readiness
Establish clear reporting structures and executive accountability.
5. Evidence of Resilience
Be prepared to demonstrate security posture to customers and regulators.
Early preparation reduces both operational risk and future compliance burden.
Frequently Asked Questions
The Cyber Security and Resilience Bill is proposed UK legislation designed to strengthen cyber security across essential services such as healthcare, energy and transport. While it focuses on critical infrastructure, it also extends expectations to suppliers and technology providers connected to those services. For medical device companies, this means cyber security is increasingly viewed as part of patient safety and operational resilience, not simply an internal IT concern. Organisations supplying connected devices or digital health platforms may need to demonstrate stronger security controls, governance and incident readiness.
Not all manufacturers will automatically fall within scope, but the Bill introduces powers for regulators to designate critical suppliers where disruption could affect essential services. Medical device providers supporting diagnostics, monitoring, clinical systems or healthcare data workflows could therefore face increased scrutiny. Even where organisations are not formally regulated, NHS procurement expectations and supply chain assurance requirements are likely to rise in line with the legislation.
Preparation should focus on resilience rather than compliance alone. Medical device organisations should understand how their systems connect into healthcare environments, ensure incidents can be detected and investigated quickly, and establish clear governance for reporting and response. Aligning with guidance from the National Cyber Security Centre, including Cyber Essentials and broader resilience frameworks, can help organisations demonstrate readiness as regulatory expectations continue to evolve.
A Turning Point for Medical Device Cyber Security
The Cyber Security and Resilience Bill signals a broader evolution in how cyber risk is understood in healthcare.
Medical device cyber security is no longer confined to technical compliance or post market patching. It is becoming a foundational component of healthcare resilience and public trust.
As connected healthcare continues to expand, organisations that treat cyber resilience as an integral part of product design and service delivery will be best positioned to operate confidently in the UK’s evolving regulatory environment.
The legislation may still be progressing through Parliament, but its message is already clear: resilience across the healthcare ecosystem is now a national priority.
Please also enjoy our Medical Device Cyber Security page and our post on FDA 510(k) Update.
